טוען...
Emerging therapies for hemophilia: controversies and unanswered questions
Several new therapies for hemophilia have emerged in recent years. These strategies range from extended half-life factor replacement products and non-factor options with improved pharmacokinetic profiles to gene therapy aiming for phenotypic cure. While these products have the potential to change he...
שמור ב:
| הוצא לאור ב: | F1000Res |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
F1000 Research Limited
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5931262/ https://ncbi.nlm.nih.gov/pubmed/29770199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.12491.1 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|